Company Directory / research

PrivateFor profitresearchSeoul, South Korea
G+FLAS Life Sciences is a biotech company that develops genome-edited crops including vitamin D3 tomatoes.
Size
11-50 people: larger than 33% of companies with a size listed
Age
12 years old.
Reach
No web traffic ranking listed.
BiopharmaBiotechnologyFood and BeverageLife Science
Funding, as listed
$38B currency not stated
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about G+FLAS Life Sciences, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
About this record
Growth, as the source summarises it
G+FLAS Life Sciences may be growing as it has established a partnership with Bayer AG to develop enhanced tomatoes, indicating a collaborative effort that could lead to advancements in agricultural biotechnology. This partnership with a major industry player suggests an expansion of G+FLAS Life Sciences' operations into new applications of genome editing. The collaboration is likely to contribute to the company's visibility and credibility in the biotech industry, potentially opening up further opportunities for growth and innovation.
Summaries written by the source dataset, not by us, and not checked.
research in South Korea.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 13,309 companies in South Korea and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.